● Recruiting

Multicenter, Phase II Randomized Controlled Study of Adebrelimab Combined With Chemotherapy and Concurrent Low-Dose Radiotherapy (LDRT) for the Treatment of Extensive-Stage Small Cell Lung Cancer (SCLC)

Condition: Small Cell Lung Cancer Extensive Stage · Sponsor: Sichuan University

PhasePhase 2

Planned participants202

Who can joinAll sexes, 18 Years to 75 Years

Healthy volunteersNo

About this study

Multicenter, Phase II Randomized Controlled Study of Adebrelimab Combined with Chemotherapy and Concurrent Low-Dose Radiotherapy (LDRT) for the Treatment of Extensive-Stage Small Cell Lung Cancer (SCLC)

This description comes directly from the study's public registry record.

Talk to the study team

You Lu · 02885424619 · radyoulu@hotmail.com

Zhuoran Yao, M.D. · yaozhuoran@outlook.com

Always discuss trial participation with your own doctor first.

Locations (1)

West China Hospital of Sichuan University

Sichuan, China

Recruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06610734